• The biotech industry might have had a rough patch in terms of investment previously because of spiraling opioid epidemic across the U.S., but today, it is on the precipice of change. With the advent of bio-analytical services and clinical trial management systems, biotech industry and pharmaceuticals are able to optimize drug development and drive quality and business performance across value...